What is the 'Healthcare Sector'

The healthcare sector consists of companies that provide medical services, manufacture medical equipment or drugs, provide medical insurance, or otherwise facilitate the provision of healthcare to patients.

BREAKING DOWN 'Healthcare Sector'

The healthcare sector is one of the largest and most complex in the U.S. economy, accounting for close to a fifth of overall gross domestic product (GDP), according to the OECD. Some of the highest-quality care in the world can be found in the U.S., but in terms of the population's overall health the U.S. lags other wealthy, developed countries. Life expectancy is 78.8 years, according to the OECD, below the club's average of 80.6 (the OECD's 35 members are mostly rich, industrialized countries in Europe and North America). 

Despite these subpar results, the U.S. spends far more than any other country on healthcare, measured per head of population: $9,892 (compared to per-person GDP of $52,321.6), two-and-a-half times the OECD average. (See also, Why Healthcare Is Broken in the U.S.)

This situation has led to a number of national reform efforts: a failed attempt by Democrats during the Clinton administration, a sweeping overhaul passed by the same party during the Obama administration (the Affordable Care Act), and a number of (so far) unsuccessful Republican efforts during the early months of the Trump administration. Investors in the health care sector face considerable political risk as a result of this push-and-pull: in the medium term, the U.S. could plausibly transition to a single-payer health system in which the federal government becomes the sole insurance provider, or a decentralized system in which states have far more leeway to structure and regulate their own health systems.

At the same time, the healthcare sector enjoys near-inelastic demand: because their health and potentially lives are at stake, patients are willing to pay almost any price for treatment, allowing many companies in the sector to earn high margins.

Industries Within the Healthcare Sector

The healthcare sector contains a diverse array of industries, with activities ranging from research to manufacturing to facilities management. 

Drugs

Drug manufacturers can further be broken down into biotechnology firms, major pharmaceuticals firms, and makers of generic drugs. The biotech industry consists of companies that engage in research and development to create new drugs, devices and treatment methods. Many of these companies are small and lack dependable sources of revenue. Their market value may depend entirely on the expectation that a drug or treatment will gain regulatory approval, and FDA decisions or rulings in patent cases can lead to sharp, double-digit swings in share prices. Examples of (larger) biotech firms include Gilead Sciences Inc. (GILD) and Celgene Corp. (GELG).

Major pharmaceuticals firms also engage in research and development, but tend to focus more on manufacturing and marketing an existing portfolio of drugs than the typical biotech firm. These companies tend to have more dependable streams of revenue and a more diversified "pipeline" of drugs in the research and development stages, making them less dependent on make-or-break drug trials and their shares less volatile. Examples of major pharmaceutical firms include Novartis AG (NVS) and GlaxoSmithKline plc (GSK).

Some pharmaceutical firms specialize in generic drugs, which are identical to name-brand drugs but no longer enjoy patent protection. As a result, there is often competition to manufacture identical drugs, leading to lower prices and thinner profit margins. An example of a generic drugs firm is Teva Pharmaceutical Industries Ltd. (TEVA).

Medical Equipment

Medical equipment makers range from firms that manufacture standard, familiar products – scalpels, forceps, bandages, gloves – to those that conduct cutting-edge research and produce expensive, high-tech equipment such as MRI machines and surgical robots. Medtronic plc (MDT) is an example of a medical equipment maker.

Managed Healthcare

Managed healthcare companies provide health insurance policies. The "Big Five" firms that dominate the industry are UnitedHealth Group Inc. (UNH), Anthem Inc. (ANTM), Aetna Inc. (AET), Humana Inc. (HUM) and Cigna Corp. (CI).

Healthcare Facilities

Health care facilities firms operate hospitals, clinics, labs, psychiatric facilities and nursing homes. Examples include Laboratory Corp. of America Holdings (LH), which operates facilities that perform blood tests and other analysis; and HCA Healthcare Inc. (HCA), which operates hospitals and other healthcare facilities in the U.S. and UK.

RELATED TERMS
  1. Abbreviated New Drug Submission ...

    A written request to Health Canada to obtain marketing approval ...
  2. Drug

    A substance that cures, treats, prevents or reduces the symptoms ...
  3. Allied Healthcare Professional ...

    Professional liability insurance that provides coverage for medical ...
  4. Abbreviated New Drug Application ...

    A written request to the U.S. Food and Drug Administration to ...
  5. New Drug

    A new medication or therapy that has not been used before in ...
  6. Orphan Drug Credit

    A federal tax credit that provides an incentive for pharmaceutical ...
Related Articles
  1. Investing

    Investing In The Healthcare Sector

    Perform a thorough checkup to uncover a medical stock with a clean bill of health.
  2. Financial Advisor

    Healthcare Funds: Give Your Portfolio A Booster Shot

    Find out how healthcare investments can become the strongest asset in your portfolio.
  3. Financial Advisor

    6 Reasons Healthcare Is So Expensive in the U.S.

    Here's why America's healthcare still ranks low among developed countries.
  4. Insights

    Why Is Health Care So Expensive In The Us?

    The U.S. is the world leader in only one area of health care: costs. Why is it so hard to rein in these expenses?
  5. Managing Wealth

    6 Common Conditions With Expensive Medications

    While the most expensive drugs may be for rare diseases, there are lots of common conditions that require some pricey prescriptions.
  6. Investing

    Using DCF In Biotech Valuation

    Valuing firms in this sector can seem like a black art, but there is a systematic way to pin a price on potential.
  7. Insights

    How Pharmaceutical Companies Price Their Drugs

    Learn more about how pharmaceutical companies price drugs, why prices are often very high and why it can be difficult to settle on a suitable price.
  8. Investing

    Healthcare ETFs See Modestly Higher Valuations

    The healthcare sector appears fairly valued, but there is still upside to be had.
  9. Investing

    Why Healthcare Has Some of the Best Sector ETFs

    The healthcare sector was a stellar performer in the first half of the year. This could continue.
  10. Insights

    7 Economic Reasons Healthcare Is Broken in the U.S.

    The U.S. healthcare market doesn't work like markets are supposed to. We asked why.
RELATED FAQS
  1. What is the drugs sector?

    Learn more about the drug industry and how new drugs are brought to market. Find out about how drug research is financed ... Read Answer >>
  2. How does the drug sector benefit from the growth of emerging markets?

    Understand how the pharmaceutical industry benefits from the growth of emerging markets. Benefits are linked to growing economies ... Read Answer >>
  3. How does government regulation impact the drugs sector?

    Learn about how drugs are regulated by the U.S. government as well as the role of the Food and Drug Administration during ... Read Answer >>
  4. What are the differences between brand name drugs and generic drugs?

    Discover the process by which brand name drugs lose their patent, allowing generics to be manufactured, as well as the differences ... Read Answer >>
  5. What factors make the drug sector good for value investing?

    Discover what makes the drugs sector good for value investing. The perfect ingredient for value investors is to find undervalued ... Read Answer >>
  6. What process does a company need to follow to bring a new drug to market?

    Learn about the costly price of bringing new drugs to market. Discover why the pharmaceutical industry invests billions of ... Read Answer >>
Hot Definitions
  1. IRR Rule

    A measure for evaluating whether to proceed with a project or investment. The IRR rule states that if the internal rate of ...
  2. Short Covering

    Short covering is buying back borrowed securities in order to close an open short position.
  3. Covariance

    A measure of the degree to which returns on two risky assets move in tandem. A positive covariance means that asset returns ...
  4. Liquid Asset

    An asset that can be converted into cash quickly and with minimal impact to the price received. Liquid assets are generally ...
  5. Nostro Account

    A bank account held in a foreign country by a domestic bank, denominated in the currency of that country. Nostro accounts ...
  6. Retirement Planning

    Retirement planning is the process of determining retirement income goals and the actions and decisions necessary to achieve ...
Trading Center